Trading / Browse Companies / ANDE Stock

ANDE Stock

ande.comBioTechFounded: 2004Funding to Date: $128.92MM

ANDE is the developer of rapid DNA analysis technology designed to help reduce crime, exonerate innocent, monitor borders, and reunite families.

Buy or sell ANDE stock
Register for Details

For more details on financing and valuation for ANDE, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for ANDE.

Register Today

ANDE investors also invested in these private companies

Eastward Capital Partners
MassVentures

Team

Management Team

George Heinrichs
Chief Executive Officer & Board Member
John Rose
Chief Financial Officer
Richard Selden
Founder, Chairman & Chief Scientific Officer
Mary Consalvi
General Counsel

Board Members

Beth Kronfeld
ANDE
David Kronfeld
ANDE
George Heinrichs
ANDE
Richard Selden
ANDE

Other companies like ANDE in the BioTech sector

Biosplice Therapeutics
Sector
BioTech
 
 
Mammoth Biosciences
Sector
BioTech
Last Round Est. Valuation
$1.08B
Grail
Sector
BioTech
Last Round Est. Valuation
$4.26B
Eikon Therapeutics
Sector
BioTech
Last Round Est. Valuation
$3.1B
Cytonics
Sector
BioTech
 
 
Resilience
Sector
BioTech
Last Round Est. Valuation
$5.81B
Element Biosciences
Sector
BioTech
Last Round Est. Valuation
$1.61B
Synthego
Sector
BioTech
Last Round Est. Valuation
$1.3B
Tessera
Sector
BioTech
Last Round Est. Valuation
$1.77B

News

AIthority 03/09/2022
ANDE Introduces Next Generation Hydrocarbon Testing Solution
ANDE Corporation, the global leader in Rapid DNA, announced the immediate availability of the F7-Chip

Trending Companies

Frequently Asked Questions